Τελευταία ενημέρωση :
19/11/2024
Ερευνητικές ομάδες - Faculty of Medical and Health Sciences, University of Auckland   pdf  
νέα Ζηλανδία
πανεπιστήμιο
Faculty of Medical and Health Sciences, University of Auckland
Auckland
Βιβλιογραφία   Βιβλιογραφία   (5)  
1
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. (d.svirskis@auckland.ac.nz)
Int J Pharm Compound - 2020 - ;24,2:140-147
2
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y. (y.gu@auckland.ac.nz)
J Oncol Pharm Practice - 2018 - ;25,4:831-840.
3
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z. (z.wu@auckland.ac.nz)
Int J Pharm Compound - 2018 - ;22,2:164-171
4
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. (d.svirskis@auckland.ac.nz)
Dysphagia - 2014 -
5
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. ()
Int J Pharm Compound - 2009 - ; 13, 3: 250-253.

Καταστάσεις   μόρια που μελετήθηκαν   (6)  
Λοιπά Αεροζόλ Citric acid
φάρμακο κατά του καρκίνου Ενέσιμο Doxorubicin hydrochloride
φάρμακο κατά του καρκίνου Ενέσιμο Etoposide phosphate
Ορμόνη Πόσιμο διάλυμα Levothyroxine
Αναστολέας της αντλίας πρωτονίων Πόσιμο διάλυμα Omeprazole sodium
φάρμακο κατά του καρκίνου Ενέσιμο Vincristine sulfate

  Mentions Légales